X0306 4 2017-12-16 false 0001100412 ARRAY BIOPHARMA INC ARRY 0001609284 Saccomano Nicholas A C/O ARRAY BIOPHARMA INC. 3200 WALNUT STREET BOULDER CO 80301 false true false false CSO Common Stock 2017-12-16 4 M false 5468.00 0.00 A 57069.00 D Common Stock 2017-12-16 4 F false 2548.00 10.92 D 54521.00 D Restricted Stock Units 0.00 2017-12-16 4 M false 5468.00 0.00 D 2020-12-16 Common Stock 5468.00 16407.00 D Restricted Stock Units 0.00 2017-12-16 4 A false 28000.00 0.00 A 2021-12-17 Common Stock 28000.00 28000.00 D Stock Option (Right to Buy) 10.92 2017-12-16 4 A false 168000.00 0.00 A 2027-12-16 Common Stock 168000.00 168000.00 D Shares issued upon settlement of Restricted Stock Units ("RSUs") granted by the Issuer on December 27, 2016 as a result of the vesting of one fourth of such RSUs. Includes 13,750 unvested RSUs awarded on April 1, 2015 to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock and which were reported by the reporting person on Table I on a form 4 filed upon grant of the RSUs. Represents shares withheld to satisfy tax withholding obligations of the reporting person. The RSUs vested on December 16, 2017. Consists of remaining unvested RSUs awarded to the reporting person for no additional cash consideration on December 16, 2016, which vest in three equal remaining installments beginning December 16, 2018, and represent a contingent right to receive one share of Array BioPharma Inc. common stock. The grant of these RSUs were previously reported on a Table II of a form 4 filed by the reporting person. Consists of RSUs awarded to the reporting person for no additional cash consideration each of which represent a contingent right to receive one share of Array BioPharma Inc. common stock. The RSUs vest and will be settled in stock in four equal annual installments beginning on December 16, 2018. The option vests in four equal annual installments beginning on December 16, 2018. Jason Haddock, attorney-in-fact for Nicholas A. Saccomano 2017-12-19